Pluxee Ups Its FY Organic Revenue Growth Target To Around +18%

Reuters07-03

Pluxee NV :Delivers Strong Growth In Q3 And Upgrades Fiscal 2024 Organic Revenue Growth Objective.Fiscal 2024 Organic Revenue Growth Objective Upgraded To Circa +18%.Fiscal 2024 Recurring Ebitda Margin And Mid-Term Financial Objectives Reiterated.Q3 Organic Revenue Growth +17.9%.Total Revenues Reached Eur 297 Mln In Q3 2024, Growing +17.9% Organically Compared To Fiscal Q3 2023.Total Business Volumes Issued Reached Eur 18.3 Bln Over The First Nine Months Of Fiscal 2024.Mid-Term Financial Objectives Are Reaffirmed.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2448875714?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-07-03 23:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2448875714","market":"sg","top_or_hot":-1,"title":"Pluxee Ups Its FY Organic Revenue Growth Target To Around +18%","media":"Reuters","content":"<html><body><p>Pluxee NV <plx.pa>:Delivers Strong Growth In Q3 And Upgrades Fiscal 2024 Organic Revenue Growth Objective.Fiscal 2024 Organic Revenue Growth Objective Upgraded To Circa +18%.Fiscal 2024 Recurring Ebitda Margin And Mid-Term Financial Objectives Reiterated.Q3 Organic Revenue Growth +17.9%.Total Revenues Reached Eur 297 Mln In Q3 2024, Growing +17.9% Organically Compared To Fiscal Q3 2023.Total Business Volumes Issued Reached Eur 18.3 Bln Over The First Nine Months Of Fiscal 2024.Mid-Term Financial Objectives Are Reaffirmed.</plx.pa></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pluxee Ups Its FY Organic Revenue Growth Target To Around +18%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPluxee Ups Its FY Organic Revenue Growth Target To Around +18%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-03 23:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.trkd.thomsonreuters.com><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pluxee NV :Delivers Strong Growth In Q3 And Upgrades Fiscal 2024 Organic Revenue Growth Objective.Fiscal 2024 Organic Revenue Growth Objective Upgraded To Circa +18%.Fiscal 2024 Recurring Ebitda ...</p>\n\n<a href=\"https://www.trkd.thomsonreuters.com\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PLX","symbol_name":"Protalix BioTherapeutics Inc","start_time":0,"source_url":"https://www.trkd.thomsonreuters.com","article_id":"2448875714","we_media_id":"1086160438","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2448875714","pubTimestamp":1720021998,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"summary":"Pluxee NV :Delivers Strong Growth In Q3 And Upgrades Fiscal 2024 Organic Revenue Growth Objective.Fiscal 2024 Organic Revenue Growth Objective Upgraded To Circa +18%.Fiscal 2024 Recurring Ebitda Margin And Mid-Term Financial Objectives Reiterated.Q3 Organic Revenue Growth +17.9%.Total Revenues Reached Eur 297 Mln In Q3 2024, Growing +17.9% Organically Compared To Fiscal Q3 2023.Total Business Volumes Issued Reached Eur 18.3 Bln Over The First Nine Months Of Fiscal 2024.Mid-Term Financial Objectives Are Reaffirmed.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"PLX":"Protalix BioTherapeutics Inc"},"translate_title":"Pluxee将财年有机收入增长目标上调至+18%左右","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PLX":0.9},"content_text":"Pluxee NV :Delivers Strong Growth In Q3 And Upgrades Fiscal 2024 Organic Revenue Growth Objective.Fiscal 2024 Organic Revenue Growth Objective Upgraded To Circa +18%.Fiscal 2024 Recurring Ebitda Margin And Mid-Term Financial Objectives Reiterated.Q3 Organic Revenue Growth +17.9%.Total Revenues Reached Eur 297 Mln In Q3 2024, Growing +17.9% Organically Compared To Fiscal Q3 2023.Total Business Volumes Issued Reached Eur 18.3 Bln Over The First Nine Months Of Fiscal 2024.Mid-Term Financial Objectives Are Reaffirmed.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2448875714"}